Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2008
03/12/2008EP1896469A2 Fused bicycloheterocycle substituted quinuclidine derivatives
03/12/2008EP1896468A1 3 -aryloxy- 8 -aza-bicyclo [3.2.1.] oct- 6- ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/12/2008EP1896467A2 Tricyclic opioid modulators
03/12/2008EP1896466A1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/12/2008EP1896465A1 Heterocyclic non-peptide gnrh antagonists
03/12/2008EP1896464A1 Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
03/12/2008EP1896463A2 Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
03/12/2008EP1896461A2 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer
03/12/2008EP1896460A1 Benzofuranyl derivatives as 5-ht6-receptor inhibitors
03/12/2008EP1896459A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
03/12/2008EP1896458A1 New 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
03/12/2008EP1896457A1 New 2-azetidinone derivatives useful in the treatment of hyperlipidaemic conditions
03/12/2008EP1896455A2 Process for the preparation of tetrazolyl compounds
03/12/2008EP1896454A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR -SECRETASE MODULATION
03/12/2008EP1896451A2 Bicyclic derivatives for the treatment of abnormal cell growth
03/12/2008EP1896450A1 2-substituted benzimidazoles
03/12/2008EP1896449A1 Heterocyclylaminoalkyl substituted benzimidazoles
03/12/2008EP1896448A1 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION
03/12/2008EP1896446A1 Novel thiophene derivatives
03/12/2008EP1896445A1 ( 6-FLU0R0-BENZ0[l, 3] DIOXOLYL) -MORPHOLIN-4-YL-METHANONES AND THEIR USE AS CBl LIGANDS
03/12/2008EP1896442A2 Thermally-processed cocoa products useful for vascular health improvement
03/12/2008EP1896438A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands
03/12/2008EP1896435A1 Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors
03/12/2008EP1896430A2 The preparation and use of compounds as aspartyl protease inhibitors
03/12/2008EP1896429A2 A purification process for anastrozole intermediate
03/12/2008EP1896428A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders
03/12/2008EP1896427A2 Novel 2-(phenylamino)benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
03/12/2008EP1896424A2 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
03/12/2008EP1896422A2 Tyrosine kinase inhibitors
03/12/2008EP1896418A1 Quinoline 3 -sulfonate esters as nk3 receptor modulators
03/12/2008EP1896417A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/12/2008EP1896416A1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
03/12/2008EP1896415A1 Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
03/12/2008EP1896414A2 3-fluoro-piperidine t-type calcium channel antagonists
03/12/2008EP1896412A2 Oxindole derivatives
03/12/2008EP1896410A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
03/12/2008EP1896409A1 Novel 2-azetidinone derivatives as cholesterol absorption inhibitors useful for the treatment of hyperlipidaemic conditions
03/12/2008EP1896408A1 New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases
03/12/2008EP1896407A1 Novel 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia
03/12/2008EP1896405A2 Organic compounds
03/12/2008EP1896404A1 Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
03/12/2008EP1896399A1 Biphenyl and naphthyl-phenyl hydroxamic acid derivatives
03/12/2008EP1896398A2 An impurity of anastrozole intermediate, and uses thereof
03/12/2008EP1896396A1 Anthranilic acid derivatives
03/12/2008EP1896394A1 Substituted enaminones as nicotinic acetylcholine receptor modulators
03/12/2008EP1896393A1 The treatment of inflammatory disorders and pain
03/12/2008EP1896392A1 A-[e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl]benzoic acid analogs and method of manufacture and and use thereof
03/12/2008EP1896391A2 Combretastatin analogs with tubulin binding activity
03/12/2008EP1896136A2 Compositions having an activity of ameliorating a reduced higher brain function resulting from organic brain lesions
03/12/2008EP1896135A2 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
03/12/2008EP1896134A2 Methods and compositions for treating degenerative bone disorders
03/12/2008EP1896084A2 Rnai modulation of hif-1 and theraputic uses thereof
03/12/2008EP1896078A1 Estrogen compositions for vaginal administration
03/12/2008EP1896077A2 Methods and compositions for the prevention and treatement of inflammatory disease
03/12/2008EP1896076A2 Compositions and methods for enhancement of sexual function
03/12/2008EP1896075A2 Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor
03/12/2008EP1896074A1 Pharmaceutical compositions for treating or preventing coronary artery disease
03/12/2008EP1896042A2 Methods and reagents for the treatment of inflammatory disorders
03/12/2008EP1896041A2 Treatment of occlusive thrombosis
03/12/2008EP1896040A2 Phosphoramidate alkylator prodrugs
03/12/2008EP1896039A2 Inhibition of epac, phospholipase c ''epsilon'', and phospholipase d to treat pain
03/12/2008EP1896038A1 Method and composition for transdermal drug delivery
03/12/2008EP1896037A2 Compositions and methods for treatment of cycle-related symptoms
03/12/2008EP1896036A1 Anti-inflammatory agents
03/12/2008EP1896035A2 Carbazole formulations for the treatment of psoriasis and angiogenesis
03/12/2008EP1896034A2 Micronized tanaproget compositions, and methods of preparing the same
03/12/2008EP1896033A2 Anti-viral compositions comprising heterocyclic substituted phenyl furans and related compounds
03/12/2008EP1896032A2 The preparation and use of compounds as protease inhibitors
03/12/2008EP1896031A1 Thiazolopyrimidines for use in therapy
03/12/2008EP1896030A1 Combinations of erbb2 inhibitors with other therapeutic agents in the treatment of cancer
03/12/2008EP1896029A1 Aminopyrimidines as kinase modulators
03/12/2008EP1896028A2 Sustained release formulation and dosing schedules of leukotriene synthesis inhibitor for human therapy
03/12/2008EP1896027A2 Topical compositions and methods for alleviating or inhibiting symptoms associated with carpal tunnel syndrome, acid reflux, psoriasis, cartilage nodules, fibromyalgia, and diabetes
03/12/2008EP1896026A2 Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
03/12/2008EP1896025A1 Scopolamine for the treatment of depression and anxiety
03/12/2008EP1896024A1 Methods and compositions using 4[(cyclopropanecarbonylamino)methyl]-2-(2,6-dioxopiperridin-3yl) isoindole-1,3-dione for the treatment of prevention of cutaneous lupus
03/12/2008EP1896023A2 Chemokine receptor binding compounds
03/12/2008EP1896022A1 Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
03/12/2008EP1896021A1 Solid pharmaceutical preparation containing (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman
03/12/2008EP1896020A1 Inhibition of osteolytic lesions by src kinase inhibitors
03/12/2008EP1896019A2 Formulation of a thienopyridine platelet aggregation inhibitor
03/12/2008EP1896018A2 Medical uses of 39-desmethoxyrapamycin and analogues thereof
03/12/2008EP1896017A2 Modulators of sperm hypermotility and uses thereof
03/12/2008EP1896016A2 Method for solubilizing metronidazole
03/12/2008EP1896015A1 Methods and compositions for the treatment of autoimmune and inflammatory diseases associated with toll-like receptors
03/12/2008EP1896014A2 Chemical compounds
03/12/2008EP1896013A1 Nuclear receptors agonists for treatment of atherosclerosis and/or related cardiovascular disease
03/12/2008EP1896012A2 Anti-inflammatory agents
03/12/2008EP1896011A1 New use
03/12/2008EP1896010A2 Method and composition to treat skin ulcers
03/12/2008EP1896009A1 Topical compositions comprising nanoparticles of an isoflavone
03/12/2008EP1896008A2 Inducing peripheral blood vessel vasodilation
03/12/2008EP1896007A2 Method of administering a cationic liposomal preparation comprising paclitexel
03/12/2008EP1896006A2 An entacapone-containging oral dosage form
03/12/2008EP1896005A1 Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease including sage and rosemary derived compounds
03/12/2008EP1896004A1 Compositions ameliorating a reduced diurnal activity and/or depressive symptoms
03/12/2008EP1896003A2 Parenteral selenomethionine for production of selenium-rich foods
03/12/2008EP1896002A2 Modified-release formulations of a bupropion salt
03/12/2008EP1896001A1 N-halogenated amino acids and n, n-dihalogenated amino acids in combination with hypohalous acids
03/12/2008EP1896000A2 Versatile high load concentrate compositions comprising metaflumizone for control of ecto-parasites
1 ... 3344 3345 3346 3347 3348 3349 3350 3351 3352 3353 3354 3355 3356 3357 3358 3359 3360 3361 3362 3363 3364 ... 7860